SCHEMBL30033042

SCHEMBL30033042

O=c1[nH]c2ccc(Cl)cc2c(=O)n1-c1cncc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.57
▸ HTT P42858 1/20 0.57
▸ GAA P10253 1/20 0.50
▸ CA12 O43570 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ NPEPPS P55786 1/20 0.46
▸ TP53 P04637 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ AURKA O14965 2/20 0.43
▸ CASP1 P29466 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ DAPK3 O43293 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033533 0.91 KDM4E (0.57) KDM4EHTTGAACA12CA9
SCHEMBL31509793 0.86 NPEPPS (0.57) KDM4EHTTGAACA12CA9
SCHEMBL30032168 0.86 NPEPPS (0.49) KDM4EHTTGAANPEPPSTP53
SCHEMBL30033413 0.84 KIF11 (0.46) KDM4EHTTGAANPEPPSTP53
SCHEMBL30034219 0.83 NPEPPS (0.43) KDM4EHTTGAANPEPPSTP53
SCHEMBL30034581 0.83 HSD17B10 (0.58) KDM4EHTTGAANPEPPSTP53
SCHEMBL30033426 0.83 NPEPPS (0.43) KDM4EHTTGAANPEPPSTP53
SCHEMBL30032902 0.83 HSP90AA1 (0.48) KDM4EHTTCA12CA9NPEPPS
SCHEMBL27377871 0.82 KDM4E (0.50) KDM4EHTTGAACA12CA9
SCHEMBL27191850 0.82 KDM4E (0.44) KDM4EHTTGAANPEPPSTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback